Tesamorelin has two Phase III lipodystrophy trials (LIPO-010 and CTR-1011), pooled analyses across 816 participants, the Stanley 2019 Lancet HIV NAFLD trial, the Stanley 2014 JAMA abdominal-fat trial, and mechanistic transcriptomic and proteomic follow-up papers
Phase 3 trial completion timeline Seven Phase 3 trials are expected to report results during this year
This prolongs the feeling of fullness and reduces the likelihood of overeating
Retatrutide for managing overweight and obesity [ID6644]
CDC data sounds alarm over obesity Data for 2023 from the Centers for Disease Control and Prevention, released this September, found that in 23 states, more than 1 in 3 adults had obesity
(PDF) Harnett, N.G., van Rooij, S.J.H., Ely, T.D., Lebois, L.A.M., Murty, V.P., Jovanovic, T., Hill, S.B., Dumornay, N.M., Merker, J.B., Bruce, S.E., House, S.L., Beaudoin, F.L., An, X., Zeng, D., Neylan, T.C., Clifford, G.D., Linnstaedt, S.D., Germine, L.T., Bollen, K.A., Rauch, S.L., Lewandowski, C., Hendry, P.L., Sheikh, S., Storrow, A.B., Musey, P.I., Jr.19, Haran, J.P., Jones, C.W., Punches, B.E., Swor, R.A., McGrath, M.E., Pascual, J.L., Seamon, M.J., Mohiuddin, K., Chang, A.M., Pearson, C., Peak, D.A., Domeier, R.M., Rathlev, N.K., Sanchez, L.D., Pietrzak, R.H., Joormann, J., Barch, D.M., Pizzagalli, D.A., Sheridan, J.F., Harte, S.E., Elliot, J.M., Kessler, R.C., Koenen, K.C., Mclean, S., Ressler, K.J., Stevens, J.S